Sierra Jorge

17PUBLICATIONS
97CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 22, 2025
Prevalence of Fms-Like Tyrosine Kinase 3 (FLT3) Mutations in Patients With Acute Myeloid Leukaemia: A Systematic Literature Review and Meta-Analysis.

Juliana F M Lewis, Naval G Daver, Noah Jamie Robinson

|Jul 23, 2025
Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation.

Sara Redondo, Irene García-Cadenas, Albert Esquirol

|Feb 06, 2025
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Adriano Venditti, Raffaele Palmieri, Luca Maurillo

|Jan 22, 2025
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.

Ana Carolina Caballero, Cristina Ujaldón-Miró, Paula Pujol-Fernández

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|Aug 12, 2024
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.

Hartmut Döhner, Courtney D DiNardo, Frederick R Appelbaum

Pageof 3

Frequent Collaborators

5 joint publications

Rodrigo Martino

5 joint publications

Irene García-Cadenas

3 joint publications

Mar Tormo

3 joint publications

Silvana Novelli